Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages
- 31 August 2005
- journal article
- research article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 165 (1-2), 139-149
- https://doi.org/10.1016/j.jneuroim.2005.05.002
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Educación, Cultura y Deporte
This publication has 51 references indexed in Scilit:
- An inflammatory linkNature, 2004
- Melatonin reduces amyloid β‐induced apoptosis in pheochromocytoma (PC12) cellsJournal of Pineal Research, 2004
- Inflammation and necrosis promote tumour growthNature Reviews Immunology, 2004
- Neuroinflammation, COX-2, and ALS—a dual role?Experimental Neurology, 2004
- Points of control in inflammationNature, 2002
- Cyclooxygenase-2: A Therapeutic TargetAnnual Review of Medicine, 2002
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellumLife Sciences, 1994
- N-Acetyltransferase activity, hydroxyindole-O-methyltransferase activity, and melatonin levels in the Harderian glands of the female Syrian hamster: Changes during the light: Dark cycle and the effect of 6-parachlorophenylalanine administrationBiochemical and Biophysical Research Communications, 1987
- N-acetyl-5-methoxy kynurenamine, a brain metabolite of melatonin, is a potent inhibitor of prostaglandin biosynthesisBiochemical and Biophysical Research Communications, 1984